Skip to main content

Peer Review reports

From: Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma

Original Submission
10 Sep 2015 Submitted Original manuscript
27 Sep 2015 Author responded Author comments - Marc-Andrea Bärtsch
Resubmission - Version 2
27 Sep 2015 Submitted Manuscript version 2
24 Feb 2016 Reviewed Reviewer Report - Chaim Shustik
27 Feb 2016 Reviewed Reviewer Report - Jatin J. Shah
7 Mar 2016 Author responded Author comments - Marc-Andrea Bärtsch
Resubmission - Version 3
7 Mar 2016 Submitted Manuscript version 3
28 Mar 2016 Reviewed Reviewer Report - Feng Gao
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
15 Apr 2016 Editorially accepted
25 Apr 2016 Article published 10.1186/s12885-016-2321-2

You can find further information about peer review here.

Back to article page